Researchers at Sandia National Laboratories are developing a medical instrument that will be able to quickly detect a suite of biothreat agents, including anthrax, ricin, botulinum, shiga and SEB toxin. Sandia's work is funded by a recent grant -- nearly $4 million over four years -- from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.